Dermatology · Sarasota, FL
NPI
1336178953
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6771 Professional Pkwy W Ste 203
Sarasota, FL, 34240
Phone (941) 907-7372
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
15,084 services
Medicare patients, 2024
1,499
Average age 75
Drug cost, 2024
$662K
676 prescriptions
Company payments, 2025
$51K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert P Finkelstein was code J3245 (injection, tildrakizumab, 1 mg), 7,400 times for 25 patients. In total Robert P Finkelstein billed 15,084 services in 74 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-08-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3245 Injection, tildrakizumab, 1 mg | Office | 7,400 | 25 | $107.65 | $797K |
| 17003 Destruction Skin Lesion | Office | 2,044 | 427 | $4.86 | $9,932 |
| 99213 Office E&M - Established | Office | 1,418 | 1,026 | $61.22 | $87K |
| 17000 Destruction Skin Lesion | Office | 894 | 645 | $39.86 | $36K |
| 99214 Office E&M - Established | Office | 817 | 531 | $90.92 | $74K |
| 17110 Destruction Skin Lesion | Office | 554 | 424 | $80.93 | $45K |
| 11102 Skin Biopsy | Office | 384 | 330 | $62.35 | $24K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 249 | 40 | $0.77 | $193 |
| 99212 Office E&M - Established | Office | 138 | 125 | $40.18 | $5,545 |
| 11103 Skin Biopsy | Office | 117 | 82 | $39.07 | $4,571 |
| 96372 Injection Administration | Office | 115 | 53 | $10.56 | $1,214 |
| 99203 Office E&M - New | Office | 110 | 110 | $75.38 | $8,292 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 93 | 79 | $306.97 | $29K |
| 96574 Skin | Office | 83 | 73 | $189.60 | $16K |
| 99204 Office E&M - New | Office | 70 | 70 | $111.26 | $7,788 |
By year: 2022 $1.1M for 13,084 services; 2023 $1.2M for 15,291 services; 2024 $1.2M for 15,084 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert P Finkelstein prescribed most often to Medicare patients was Ciclopirox (Ciclopirox Olamine), with 59 prescriptions and refills. In total Robert P Finkelstein wrote 676 Medicare prescriptions that cost $662K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ciclopirox Ciclopirox Olamine | 59 | 63 | 37 | $1,142 |
| Ketoconazole Generic | 51 | 53 | 35 | $730 |
| Betamethasone Dipropionate Generic | 43 | 44 | 26 | $1,817 |
| Triamcinolone Acetonide Generic | 42 | 46 | 35 | $510 |
| Valacyclovir Valacyclovir Hcl | 41 | 41 | 18 | $443 |
| Doxycycline Hyclate Generic | 37 | 41 | 24 | $738 |
| Clobetasol Propionate Generic | 24 | 24 | 19 | $1,390 |
| Mupirocin Generic | 22 | 22 | 22 | $138 |
| Metronidazole Generic | 22 | 28 | 19 | $1,131 |
| Betamethasone Valerate Generic | 21 | 21 | 14 | $590 |
| Imiquimod Generic | 17 | 18 | 11 | $442 |
| Fluorouracil Generic | 17 | 17 | 16 | $1,160 |
| Terbinafine Hcl Generic | 16 | 22 | Under 11 | $173 |
| Prednisone Generic | 15 | 27 | Under 11 | $108 |
| Gentamicin Sulfate Generic | 15 | 15 | 13 | $450 |
Brand drugs: 83 claims; generic drugs: 593 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert P Finkelstein $51K ($51K in general payments such as food, travel and fees) from 21 companies. The largest payer was UCB, Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 31 | $17K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $12K |
| Abbvie Inc. ABBV | 25 | $12K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 19 | $8,421 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $217 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $156 |
| Galderma Laboratories, L.P. GALD.SW | 13 | $144 |
| Pfizer Inc. PFE | 7 | $139 |
| LEO Pharma Inc. | 4 | $114 |
| Incyte Corporation INCY | 4 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.